NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 112
- 13F valueReported value at the end of Q2 2026
- $422.4M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NPCE, Q2 2026
No superinvestor reported holding NPCE at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by NeuroPace Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 (view filing) | Dec 15, 2025 | 79 daysLate | Morrell MarthaCHIEF MEDICAL OFFICER | SSale | −25.0K | $15.97 | −$399.3K | −33.3%50.0K after | |
| May 16, 2025 (view filing)5:26 PM ET | May 14 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −168.1K | $15.85 | −$2.67M | −4.9%3.24M after | 2 lots |
| Feb 25, 2025 (view filing) | Feb 21 | 4 days | Morrell MarthaCHIEF MEDICAL OFFICER | SSale | −78.3K | $13.72 | −$1.07M | −48.9%82.0K after | |
| Feb 20, 2025 (view filing) | Feb 20 | Same day | KCK Ltd.10% Owner | SSale | −5.27M | $9.40 | −$49.5M | −100.0%0 after | |
| Jan 31, 2025 (view filing) | Jan 29-30 | 2 days | Morrell MarthaCHIEF MEDICAL OFFICER | SSale | −300 | $15.00 | −$4.50K | −0.3%86.8K after | 2 lots10b5-1 |
| Jan 28, 2025 (view filing) | Jan 24 | 4 days | Morrell MarthaCHIEF MEDICAL OFFICER | SSale | −3.20K | $15.01 | −$48.0K | −3.5%87.1K after | 10b5-1 |
| Oct 28, 2024 (view filing) | Oct 23-25 | 5 daysLate | KCK Ltd.10% Owner | SSale | −224.1K | $5.45 | −$1.22M | −4.1%5.27M after | 2 lots |
| Oct 24, 2024 (view filing) | Oct 22 | 2 days | KCK Ltd.10% Owner | SSale | −4.08K | $6.09 | −$24.9K | −0.1%5.49M after | |
| Oct 22, 2024 (view filing) | Oct 18-21 | 4 days | KCK Ltd.10% Owner | SSale | −8.60K | $6.21 | −$53.4K | −0.2%5.50M after | 2 lots |
| Oct 18, 2024 (view filing) | Oct 3-17 | 15 daysLate | KCK Ltd.10% Owner | SSale | −46.4K | $6.54 | −$303.4K | −0.8%5.51M after | 11 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in NeuroPace Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Capital Holdings Plc | 3,298,104 | $52.4M | 0.15% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 2,911,122 | $46.3M | 1.59% | −21,085−0.7% | Reduced |
| First Light Asset Management, LLC | 2,861,167 | $45.5M | 2.76% | +401,201+16.3% | Added |
| Morgan Stanley | 2,654,391 | $42.2M | 0.00% | +87,552+3.4% | Added |
| BlackRock, Inc. | 2,477,603 | $39.4M | 0.00% | +131,270+5.6% | Added |
| OrbiMed Advisors LLC | 1,505,125 | $23.9M | 0.45% | −591,402−28.2% | Reduced |
| Driehaus Capital Management LLC | 1,447,391 | $23.0M | 0.13% | −4,220−0.3% | Reduced |
| Vanguard Capital Management LLC | 1,227,072 | $19.5M | 0.00% | +103,361+9.2% | Added |
| Deutsche Bank AG | 938,919 | $14.9M | 0.00% | +6,829+0.7% | Added |
| Armistice Capital, LLC | 692,000 | $11.0M | 0.30% | 00.0% | Unchanged |